December 9, 2005
Death toll from bird flu hits 70 as Thai boy dies
By Panarat Thepgumpanat and Maggie Fox
BANGKOK/WASHINGTON (Reuters) - A Thai boy has become the 70th Asian to die of bird flu, authorities said on Friday, as reports warned a flu pandemic could cost the U.S. economy hundreds of billions of dollars as well as millions of lives.
The World Health Organization (WHO) said it may seek to investigate control measures in the area, which has not reported any other human cases.
The death of the 5-year-old boy from the central province of Nakhon Nayok, 110 km (70 miles) from Bangkok, took Thailand's bird flu death toll to 14 out of 22 known cases since the virus swept through large parts of Asia in late 2003.
It was not certain how the boy caught the virus, which usually strikes those in close contact with infected fowl or their droppings, senior health officials said. The boy, who died in hospital on Wednesday, was not known to have had direct contact with chickens, health officials said.
"We believe that the boy contracted the virus from his surroundings because, although his family does not raise chickens, there are chickens raised in his neighborhood," said Thawat Suntrajarn, head of the Health Ministry's Disease Control Department.
That would follow the usual pattern of human infections of the virus, which has not yet shown signs of evolving into a form which could pass easily from person to person.
Experts say that is the great fear. If the H5N1 virus did acquire that ability, it could set off a pandemic which could kill millions of people without immunity to the new strain.
The virus is now endemic in poultry in parts of Asia and countries around the world are preparing plans to deal with a pandemic which could cause massive economic losses as well as millions of deaths.
A pandemic could cause a serious recession in the U.S. economy, with immediate costs of between $500 and $675 billion, according to two new reports.
New Jersey based WBB Securities LLC predicted a pandemic could cause a one-year economic loss of $488 billion and a permanent economic loss of $1.4 trillion to the U.S. economy.
The World Bank has predicted a pandemic could cost the global economy $800 billion a year.
If the virus mutates into a form which passes between humans, it is likely to closely resemble the 1918 pandemic strain of flu that killed anywhere between 20 million and 100 million people, separate reports released by WBB and the Congressional Budget Office (CBO) said.
This means 30 percent of the population would be infected and more than 2 percent would die, the report from the CBO said.
"Further, CBO assumed that those who survived would miss three weeks of work, either because they were sick, because they feared the risk of infection at work, or because they needed to care of family or friends," the report reads.
The CBO said a pandemic could deal a $675 billion hit to the U.S. economy.
Hospitals would have difficulty controlling infection and might become sources for spreading the illness, the CBO said -- a fear echoed by another group, the National Center for Policy Analysis.
U.S. President George W. Bush released a $7.1 billion bird flu plan in November but Congress has yet to fund it.
In a boost for countries seeking the antiviral drug Tamiflu, one of four drugs known to work against influenza, Swiss manufacturer Roche reached agreements with two U.S. generic drugmakers, as well as 13 other drug producers, U.S. Senator Charles Schumer said.
The agreements are meant to allow more production of the drug, known generically as oseltamivir, in case of an avian flu pandemic, Schumer, a New York Democrat, said in a statement.
Countries are seeking to stockpile the drug but all are many million doses short of what would be needed to treat a pandemic.
Last month, Roche said Indonesia, Thailand and the Philippines were free to begin making their own versions of the pill because it does not have patent protection in those countries.
Doctors believe Tamiflu may help control a pandemic of H5N1 influenza, although evidence suggests it may be less effective than it is against seasonal flu.
(Additional reporting by Kanokwan Boonngok in Bangkok; Richard Cowan, Susan Heavey and Maggie Smith in Washington; Emma Graham-Harrison in Beijing and Stephanie Nebehay in Geneva)